| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.19 | 0.09 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |